Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARIO CARLOS RIVERA

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1841670445
CMS profile
7958894
Location
FARGO, ND

General Payments · PY2020–2024

$1,030.47

  • Reported across 66 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$278.47

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $278.47 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABIOMED $171.26 10
Medtronic, Inc. $25.29 1
Novo Nordisk AS $19.50 1
Tandem Diabetes Care, Inc. $19.35 1
Abbott Laboratories $16.63 1
Boehringer Ingelheim Pharmaceuticals, Inc. $13.32 1
SANOFI-AVENTIS U.S. LLC $13.12 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2020 $24.22 2
PY2021 $123.40 7
PY2022 $390.31 30
PY2023 $214.07 11
PY2024 $278.47 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $16.63 01/28/2024 Food and Beverage Undisputed 01/23/2026 1125301021 CMS
ABIOMED $42.65 05/18/2024 Food and Beverage Undisputed 01/23/2026 1142311786 CMS
ABIOMED $3.31 06/18/2024 Food and Beverage Undisputed 01/23/2026 1142311788 CMS
ABIOMED $5.44 07/03/2024 Food and Beverage Undisputed 01/23/2026 1142311790 CMS
ABIOMED $9.41 08/10/2024 Food and Beverage Undisputed 01/23/2026 1142311794 CMS
ABIOMED $4.08 08/15/2024 Food and Beverage Undisputed 01/23/2026 1142311792 CMS
ABIOMED $23.17 09/03/2024 Food and Beverage Undisputed 01/23/2026 1142311798 CMS
ABIOMED $14.29 09/13/2024 Food and Beverage Undisputed 01/23/2026 1142311796 CMS
ABIOMED $24.46 10/23/2024 Food and Beverage Undisputed 01/23/2026 1142311804 CMS
ABIOMED $22.33 11/02/2024 Food and Beverage Undisputed 01/23/2026 1142311802 CMS
ABIOMED $22.12 11/04/2024 Food and Beverage Undisputed 01/23/2026 1142311800 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.32 03/12/2024 Food and Beverage Undisputed 01/23/2026 1118180407 CMS
Medtronic, Inc. $25.29 03/28/2024 Food and Beverage Undisputed 01/23/2026 1119513335 CMS
Novo Nordisk Inc $19.50 04/09/2024 Food and Beverage Undisputed 01/23/2026 1096852082 CMS
SANOFI-AVENTIS U.S. LLC $13.12 04/30/2024 Food and Beverage Undisputed 01/23/2026 1139932339 CMS
Tandem Diabetes Care, Inc. $19.35 05/13/2024 Food and Beverage Undisputed 01/23/2026 1138751859 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.